Related Experiment Video
Updated: Oct 3, 2025

06:55
Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing
Published on: May 8, 2021
5.7K
Repeatability and reproducibility of a handheld quantitative G6PD diagnostic
Benedikt Ley1, Ari Winasti Satyagraha2, Mohammad Golam Kibria3
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.
Plos Neglected Tropical Diseases
|February 17, 2022
Summary
The STANDARD G6PD test shows good precision for diagnosing glucose-6-phosphate dehydrogenase deficiency. However, it struggles to differentiate intermediate from low G6PD activity in lyophilized samples, requiring further clinical evaluation.
Area of Science:
- Medical Diagnostics
- Point-of-Care Testing
- Malaria Diagnostics
Background:
- Accurate diagnosis of glucose-6-phosphate dehydrogenase (G6PD) deficiency is crucial for radical cure regimens of Plasmodium vivax.
- Quantitative G6PD measurement is necessary for females due to their genetic make-up.
- SD Biosensor developed a handheld quantitative G6PD diagnostic device for point-of-care use.
Purpose of the Study:
- To evaluate the precision and reproducibility of the STANDARD G6PD test.
- To compare the device's performance against spectrophotometry.
- To determine the suitability of the device for routine clinical care.
Main Methods:
- Lyophilized G6PD controls (high, intermediate, low) were tested on multiple Biosensor devices.
- Devices were distributed to 10 laboratories for inter-laboratory reproducibility testing.
- Results were compared to spectrophotometry measurements.
Main Results:
- The STANDARD G6PD test demonstrated good repeatability and inter-laboratory reproducibility.
- High correlation was observed between Biosensor readings and spectrophotometry (rs = 0.859) when tested at a single site.
- Lower correlation (rs = 0.604) was found in inter-laboratory tests, with overlapping G6PD activity for low and intermediate controls.
Conclusions:
- The Biosensor device exhibits good precision but has limitations in discriminating between intermediate and low G6PD activities using lyophilized specimens.
- Further clinical studies are needed to validate the device's performance in real-world settings.
- The device's potential for routine use in G6PD deficiency diagnosis requires further assessment.

